Visit our Covid 19 and Preeclampsia resource page. Click Here

Last Updated on February 06, 2020

About the Preeclampsia Registry

PR_logo_fullcolor.png (75 KB)

Launched in 2013, the Preeclampsia Registry was built to create a partnership between preeclampsia survivors and researchers to advance our understanding of preeclampsia. As participants share their experiences, approved researchers are provided with access to “de-identified” health information – information that does not contain participant names or contact information. This helps researchers to find patterns that can lead to findings and further studies. The registry also accelerates studies as researchers are able to gather cohorts for new studies or pose new questions.

The Preeclampsia Registry also gives its participants the option of learning about other research studies for which they may qualify and provides them with the means of connecting with researchers.

Most importantly, patient registries unite the patient voice with research. Patients have questions, theories, and interests that are often different from investigators conducting formal research. By engaging patients in the research process, as we can through patient registries, the chances for discovery and improvement are an even greater possibility.

About the Preeclampsia Foundation

PF-LOGO-2019_fullcolor-smallsize.png (19 KB)

Established in 2000, the Preeclampsia Foundation is the only national 501(c)(3) not-for-profit patient advocacy organization serving the 5-8% of pregnant women - approximately 300,000 women each year in the U.S. - who are affected by hypertensive disorders of pregnancy such as preeclampsia (formerly known as toxemia), eclampsia, and HELLP syndrome. We are advised by a Medical Advisory Board comprised of top medical and scientific experts in preeclampsia and related fields, and partner with other non-profit organizations, governmental agencies, academic institutions, and corporations to achieve our mission. Our Non-Profit Tax ID Number is 91-2073087.

Scientific Advisory Council

The Scientific Advisory Council (SAC) played a key role in the development of the Preeclampsia Registry and continues to be essential to its integrity. The SAC provides representation amongst many disciplines including epidemiology, internal medicine, pediatrics, nephrology, genomics, obstetrics and gynecology (including Maternal Fetal Medicine), industry, National Institutes of Health, Centers for Disease Control, patient/consumer, and the Preeclampsia Foundation Medical Medical Advisory Board.

  • Jim Roberts, MD


    University of Pittsburgh

    Magee Women's Research Institute

  • Arun Jeyabalan, MD

    University of Pittsburgh

  • Michelle Owens, MD

    University of Mississippi

  • Janet Rich-Edwards, ScD

    Harvard Medical School

  • Ellen Seely, MD

    Brigham and Women's Hospital

  • Eleni Tsigas, BA

    Preeclampsia Foundation, Chief Executive Officer

    • Sarosh Rana, MD M.P.H.


      The University of Chicago

    • Hilary Gammill, MD

Bill and Melinda Gates Foundation

  • Ananth Karumanchi, MD

    Howard Hughes Research Institute

    Harvard Medical School

  • Emily Petersen, MD

    Centers for Disease Control and


  • Alison Roberts, CNM

    West Berkeley Family Practice

  • Kent Thornburg, PhD

    Oregon Health and Science University

  • Tom Easterling, MD

    University of Washington

  • Kyu-Ho Lee, MD PhD

    Medical University of South Carolina

  • Robert Powers, PhD

    University of Pittsburgh

  • Donna Russell, MHA

    Donna Russell Consulting, LLC

  • Rebecca Troisi, ScD

    National Cancer Institute

    National Institutes of Health

  • Kenneth Ward, MD

    Juneau Biosciences

  • Alina Brewer, BA (ex-officio)

    Preeclampsia Foundation, Registry Manager

Steering Committee

The Preeclampsia Foundation believes that to be effective stewards, it is essential to be transparent about research practices and intentions, and to communicate openly and clearly with participants. For this reason, the Preeclampsia Registry Steering Committee was organized to develop policies related to data gathering, validation, sharing, and research priorities. This committee is comprised of members of the Preeclampsia Foundation's Patient, Scientific, and Corporate Advisory Councils, Medical Advisory Board, and Board of Directors.

The Steering Committee is responsible for reviewing proposals from researchers seeking to use data from the registry and developing key policies.

  • Eleni Tsigas, BA

    Principal Investigator

  • Hilary Gammill, MD

    Scientific Advisory Council

  • Alina Brewer, BA

    Registry Manager

  • Jim Roberts, MD

    Scientific Advisory Council

  • Norlisa Abernica-Kefffer

    Patient Advocate

  • Tom Easterling, MD

    Medical Advisory Board

Related Articles